Phase
Condition
Occlusions
Cerebral Ischemia
Thrombosis
Treatment
Magneto Microcatheter
Clinical Study ID
Ages 18-85 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Clinical signs consistent with acute ischemic stroke
Patient with Acute Ischemic Stroke within 24 hours from symptoms o
Age 18-85 years old
Consent process is completed per international and local regulations
Exclusion
Exclusion Criteria:
Known use of cocaine or other vasoactive substance
Known bleeding diathesis
Any known hemorrhagic or coagulation deficiency.
Current use of oral anticoagulants with International Normalized Ratio (INR) > 3;
PTT (Partial Thromboplastin Time)>2 at screening
Uncontrolled hypertension (Systolic blood pressure>185 or Diastolic bloodpressure>110) refractory to pharmacological management
Pregnant or lactating female
CT scan or MRI with evidence of acute intracranial hemorrhage, ASPECT score<6, masseffect and/or intracranial tumor
Angiographic evidence of either carotid dissection or vasculitis at the target siteor any condition that may limit device access to the target site (i.e high gradestenosis) per the treating physician's discretion.
Study Design
Connect with a study center
National Institute of Mental Health, Neurology and Neurosurgery)
Budapest,
HungarySite Not Available
Shaare Zedek
Jerusalem,
IsraelSite Not Available
Sheba Medical Center
Ramat Gan,
IsraelSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.